VanEck Pharmaceutical ETF
PPH
PPH
62 hedge funds and large institutions have $59.2M invested in VanEck Pharmaceutical ETF in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
74% less call options, than puts
Call options by funds: $369K | Put options by funds: $1.41M
Holders
62
Holding in Top 10
1
Calls
$369K
Puts
$1.41M
Top Buyers
| 1 | +$3.98M | |
| 2 | +$1.88M | |
| 3 | +$1.1M | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$968K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$792K |
Top Sellers
| 1 | -$6.5M | |
| 2 | -$5.01M | |
| 3 | -$1.79M | |
| 4 |
Morgan Stanley
New York
|
-$1.43M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.04M |